OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
171060

Oriental Union Chemical Corp

Commodity ChemicalsVerified

Oriental Union Chemical Corp has a debt-to-equity ratio of 1.74 and a current ratio of 0.57, indicating a high reliance on debt and limited short-term liquidity to cover immediate liabilities. The company’s cash and equivalents of TWD 153.8 million are significantly lower than its long-term debt of TWD 16.04 billion, resulting in a negative net cash position after subtracting total debt. The company reported a net loss of TWD 887.29 million and an operating loss of TWD 902.48 million in the latest period, with a return on equity of -9.64% and a return on assets of -2.74%. These metrics suggest poor profitability and asset utilization relative to the Commodity Chemicals industry, where positive returns and gross margins are typically expected. The company’s revenue is concentrated in disclosed segments: ethylene glycol, industrial gases, and specialty chemicals. Geographic exposure is primarily in Taiwan, Mainland China, and other Asian markets, with additional sales in Africa, Europe, and the Americas. No segment-specific revenue breakdown is provided, but the lack of diversification increases exposure to regional demand shifts. Analysts expect a modest improvement in earnings, with a mean EPS estimate of TWD 1.04 for the current fiscal year, compared to a loss of TWD 1.01 in the last reported period. However, the company’s negative operating cash flow of TWD -91.12 million and free cash flow of TWD -1.03 billion suggest ongoing cash generation challenges, which may constrain growth initiatives or debt servicing. The company faces medium liquidity risk and low dilution risk, with no near-term pressure from share issuance or convertible debt. However, the negative net cash position and high debt load could limit flexibility in volatile market conditions. No recent filings or transcripts indicate material changes in strategy or operations. The company’s capital expenditure of TWD -927.84 million reflects ongoing investment in operations, but the negative free cash flow suggests these expenditures are not yet generating sufficient returns. Analysts have issued two "Hold" ratings and no "Buy" or "Sell" recommendations, reflecting cautious sentiment.

30-day price · 1710-0.70 (-5.1%)
Low$11.45High$14.75Close$13.10As of22 May, 00:00 UTC
Profile
CompanyOriental Union Chemical Corp
Ticker1710.TW
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Oriental Union Chemical Corp (1710.TW) is a Taiwan-based manufacturer and distributor of chemical products, including ethylene glycol, industrial gases, and specialty chemicals, primarily serving markets in Asia, Africa, Europe, and the Americas.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Oriental Union Chemical Corp has a debt-to-equity ratio of 1.74 and a current ratio of 0.57, indicating a high reliance on debt and limited short-term liquidity to cover immediate liabilities. The company’s cash and equivalents of TWD 153.8 million are significantly lower than its long-term debt of TWD 16.04 billion, resulting in a negative net cash position after subtracting total debt. The company reported a net loss of TWD 887.29 million and an operating loss of TWD 902.48 million in the latest period, with a return on equity of -9.64% and a return on assets of -2.74%. These metrics suggest poor profitability and asset utilization relative to the Commodity Chemicals industry, where positive returns and gross margins are typically expected. The company’s revenue is concentrated in disclosed segments: ethylene glycol, industrial gases, and specialty chemicals. Geographic exposure is primarily in Taiwan, Mainland China, and other Asian markets, with additional sales in Africa, Europe, and the Americas. No segment-specific revenue breakdown is provided, but the lack of diversification increases exposure to regional demand shifts. Analysts expect a modest improvement in earnings, with a mean EPS estimate of TWD 1.04 for the current fiscal year, compared to a loss of TWD 1.01 in the last reported period. However, the company’s negative operating cash flow of TWD -91.12 million and free cash flow of TWD -1.03 billion suggest ongoing cash generation challenges, which may constrain growth initiatives or debt servicing. The company faces medium liquidity risk and low dilution risk, with no near-term pressure from share issuance or convertible debt. However, the negative net cash position and high debt load could limit flexibility in volatile market conditions. No recent filings or transcripts indicate material changes in strategy or operations. The company’s capital expenditure of TWD -927.84 million reflects ongoing investment in operations, but the negative free cash flow suggests these expenditures are not yet generating sufficient returns. Analysts have issued two "Hold" ratings and no "Buy" or "Sell" recommendations, reflecting cautious sentiment.
Key takeaways
  • The company is highly leveraged, with a debt-to-equity ratio of 1.74 and a negative net cash position.
  • Profitability is weak, with a net loss of TWD 887.29 million and a return on equity of -9.64%.
  • Revenue is concentrated in a few chemical segments and geographic regions, increasing exposure to demand volatility.
  • Analysts expect a modest EPS improvement but have not issued any "Buy" ratings, reflecting cautious sentiment.
  • --
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$22.25B
Gross profit$191.8M
Operating income-$902.5M
Net income-$887.3M
R&D
SG&A
D&A
SBC
Operating cash flow-$91.1M
CapEx-$927.8M
Free cash flow-$1.03B
Total assets$32.35B
Total liabilities$23.15B
Total equity$9.21B
Cash & equivalents$153.8M
Long-term debt$16.04B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$9.21B
Net cash-$15.89B
Current ratio0.6
Debt/Equity1.7
ROA-2.7%
ROE-9.6%
Cash conversion10.0%
CapEx/Revenue-4.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric1710Activity
Op margin-4.1%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-4.0%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin0.9%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity174.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.04 TWD
Last actual EPS-1.01 TWD
Last actual revenue22,253,718,000 TWD
market data ESG controversies score100.0
market data ESG governance pillar12.3
market data ESG social pillar45.3
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 17:06 UTC#31389ef3
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 10:51 UTCJob: 8dcbce73